REJUVERON LIFE SCIENCES
Rejuveron Life Sciences AG is a fully integrated biotechnology platform company that invests in people and ideas to develop therapies and technologies to improve healthy aging and prolong lifespan.
REJUVERON LIFE SCIENCES
Social Links:
Industry:
Biotechnology Health Care Medical
Founded:
2019-01-01
Status:
Active
Email Addresses:
[email protected]
Total Funding:
25.01 M USD
Technology used in webpage:
Content Delivery Network Metanet
Similar Organizations
Rakuten Medical
Rakuten Medical is a Bio-technology Company.
Knopp Biosciences
Knopp Neurosciences is a drug discovery and development company working on treatments for neurological disorders.
Remix Therapeutics
Remix Therapeutics is a biotechnology company.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Current Employees Featured
Founder
Investors List
What If Ventures
What If Ventures investment in Series B - Rejuveron Life Sciences
re.Mind Capital
re.Mind Capital investment in Series B - Rejuveron Life Sciences
Apeiron Investment Group
Apeiron Investment Group investment in Series B - Rejuveron Life Sciences
Gaingels
Gaingels investment in Series B - Rejuveron Life Sciences
Ava Investors
Ava Investors investment in Series B - Rejuveron Life Sciences
10X Capital
10X Capital investment in Series A - Rejuveron Life Sciences
Korify Capital AG
Korify Capital AG investment in Series A - Rejuveron Life Sciences
infinitas capital group
infinitas capital group investment in Series A - Rejuveron Life Sciences
Gaingels
Gaingels investment in Series A - Rejuveron Life Sciences
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-12-13 | Endogena | Rejuveron Life Sciences investment in Series A - Endogena | 21 M USD |
| 2021-10-12 | Rejuvenate Biomed | Rejuveron Life Sciences investment in Series B - Rejuvenate Biomed | 15.7 M EUR |
| 2021-01-28 | Endogena | Rejuveron Life Sciences investment in Series A - Endogena | 8 M USD |
Key Employee Changes
| Date | New article |
|---|---|
| 2021-11-19 | Rejuveron Appoints Roche Veteran Bob Silverman as Chief Business Officer and Opens US Operations in New York |
More informations about "Rejuveron Life Sciences"
Rejuveron Life Sciences AG Rebrands as Centenara Labs AG and …
Sep 19, 2024 Centenara Labs AG (“Centenara” or the “Company”) (formerly Rejuveron Life Sciences AG), a Zurich-based biotechnology company focused on pioneering therapies to …See details»
Rejuveron Life Sciences - Crunchbase
Rejuveron Life Sciences AG is a fully integrated biotechnology platform company that invests in people and ideas to develop therapies and technologies to …See details»
Rejuveron Life Sciences AG Rebrands as Centenara Labs AG and
Sep 19, 2024 SCHLIEREN, Switzerland, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Centenara Labs AG (“Centenara” or the “Company”) (formerly Rejuveron Life Sciences AG), a Zurich …See details»
Rejuveron Life Sciences AG Rebrands as Centenara Labs AG and …
Sep 19, 2024 SCHLIEREN, Switzerland, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Centenara Labs AG (“Centenara” or the “Company”) (formerly Rejuveron Life Sciences AG), a Zurich …See details»
Rejuveron Life Sciences rejuvenates as Centenara Labs
Sep 23, 2024 The biotech, as Rejuveron Life Sciences AG, raised $75 million in dual tranche series B and convertible loan financing one year ago this month and is focused on a small …See details»
Centenara Labs AG – Swiss Biotech
Rejuveron is an integrated biotechnology platform company that develops and improves therapies and technologies to promote healthy aging and prolong lifespan. ... Type of organization. …See details»
Rejuveron Life Sciences - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors ... Venture Round - Rejuveron …See details»
Rejuveron Life Sciences - Org Chart, Teams, Culture & Jobs - The …
Rejuveron Life Sciences is a fully integrated biotechnology platform company that invests in people and ideas to develop therapies. Industries. Biotechnology, Health Care. Headquarters. …See details»
Rejuveron Transitions to Become a Clinical Stage Company as …
Mar 28, 2022 Schlieren, Zürich, Switzerland · 29 March 2022. Rejuveron Life Sciences AG (‘Rejuveron’), a Zürich-based biotechnology company developing therapies to promote healthy aging, today announced that Rejuvenate Biomed NV (‘Rejuvenate’) has commenced its first Phase 1 clinical trial assessing the company’s lead candidate RJx-01 for the treatment of …See details»
Rejuveron Increases to Near-majority Stake in Endogena Through …
Dec 12, 2021 Rejuveron Life Sciences AG, a Zürich-based biotechnology company developing technologies for healthy aging, today announced that it has strengthened its support to a near …See details»
Rejuveron Life Sciences AG – Swiss Biotech
Rejuveron is an integrated biotechnology platform company that develops and improves therapies and technologies to promote healthy aging and prolong lifespan. We provide start-up coaching …See details»
Our purpose - backend.rejuveron.com
At Rejuveron, we focus on the one compelling reason to scientifically explore an idea.\/p>\n ... longer lives. Our goal is to expand the health span of human beings, enabling all of us to enjoy …See details»
Rejuveron Life Sciences - EU-Startups
Rejuveron Life Sciences is a fully integrated biotechnology platform company that invests in people and ideas to develop therapies. Rejuveron is a clinical-stage biotechnology company …See details»
Rejuveron Life Sciences AG - startup.ch
Rejuveron Life Sciences AG: Rejuveron is a clinical-stage biotechnology company creating therapies to improve healthy aging. Its experienced drug discovery and development team …See details»
Creating therapies for improved aging and longer lives - Nature
Rejuveron Life Sciences AG. Peter Sandbach, Communications Director, Rejuveron Life Sciences AG, Schlieren-Zürich, Switzerland, Tel: +41 79 500 9824 ... According to the World Health Organization ...See details»
Rejuveron leads EUR 15.7 million Series B investment in …
Oct 11, 2021 Rejuveron Life Sciences AG is a fully integrated biotechnology platform company that invests in people and ideas to develop therapies and technologies to improve healthy …See details»
Rejuveron funds $29 million for degenerative eye disease
Dec 13, 2021 Rejuveron Life Sciences AG, a Zürich-based biotechnology company developing technologies for healthy aging, today announced that it has strengthened its support to a near-majority holding in Endogena Therapeutics Inc, an endogenous regenerative therapeutics company.Rejuveron has funded a further $20m in the $29 million series A financing round to …See details»
Rejuveron Life Sciences - Company Profile - Tracxn
4 days ago Rejuveron Life Sciences - Developer of drugs for treating age related diseases. Raised a total funding of $76.3M over 2 rounds from 14 investors. Founded by Marc Ramis …See details»
Rejuveron Life Sciences funding & investors - Tracxn
Nov 26, 2024 Rejuveron Life Sciences has raised a total funding of $76.3M over 2 rounds from 14 investors. Investors include Daniel Gutenberg, Gaingels and 12 others. Their latest funding …See details»
Centenara Labs Company Profile 2024: Valuation, Funding
Dec 13, 2019 Centenara Labs General Information Description. Developer of intensive drug therapies designed to improve and prolong the human lifespan. The company's drugs focus on finding cures for age-related diseases and advancing science and technology and offer services such as drug discovery expertise, financial support, legal and admin services and other related …See details»